Among innov. pharmas, Celltrion invested the most into R&D

Published: 2016-10-17 12:21:35

Updated: 2016-10-17 12:21:35

Among the innovative pharmaceutical companies, Celltrion invested the largest amount into pharmaceutical R&D, and CrystalGenomics recorded the highest R&D/sales investment ratio.

According to the analysis result of the ‘Innovative Pharmaceutical Companies’ R&D Investment Status’ turned in by the Korea Health Industry Development Institute(KHIDI) as a material for the National Inspection, Il-So...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.